TITLE

GENE WATSON ON TOUR

AUTHOR(S)
Cackett, Alan
PUB. DATE
April 2011
SOURCE
Maverick;Apr2011, Issue 105, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article features U.S. country music vocalist Gene Watson and his touring schedule in Great Britain in 2011. Among his top singles were "Love in the Hot Afternoon" and "Where Love Begins." His touring schedule slowed down due to colon cancer and the chemotherapy treatment. Warner Bros. will release "Randy's 25th Anniversary Album" which features Watson and Randy Travis in 2011.
ACCESSION #
66844174

 

Related Articles

  • Second-line irinotecan noninferior to FOLFOX4 in FU-refractory colorectal carcinoma.  // Hem/Onc Today;5/25/2009, Vol. 10 Issue 10, p33 

    The article discusses research which demonstrated that patients with FU-refractory patients with metastic colorectal cancer treated with second-line irinotecan showed similar results with patients treated with FOLFOX4, conducted by G. P. Kim et al, published in a 2009 issue of the "Journal of...

  • Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma. Ohtsu, A; Baba, H; Sakata, Y; Mitachi, Y; Horikoshi, N; Sugimachi, K; Taguchi, T // British Journal of Cancer;7/15/2000, Vol. 83 Issue 2, p141 

    This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and toxicity of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of...

  • Recent advances in chemotherapy and chemoradiotherapy for gastrointestinal tract cancers. Watanabe, Toshiaki // International Journal of Clinical Oncology;Dec2008, Vol. 13 Issue 6, p472 

    The article discusses various reports published within the issue including one on colorectal cancer. by Van Rijnsoever and colleagues and another on chemotherapy for colon cancer by T. Watanabe and colleagues.

  • Adjuvant chemotherapy in colorectal cancer.  // British Medical Journal;8/7/1976, Vol. 2 Issue 6031, p342 

    Examines the effectiveness of adjuvant chemotherapy in colorectal cancer in Great Britain. Possibility of the palliative resection for the spread tumor diagnosis; Benefit of the adjuvant chemotherapy program; Justiciability of early intervention with effective chemotherapeutic regimen.

  • Needle-Free Home Chemo. Harrar, Sari; J.M. // Prevention;Sep2002, Vol. 54 Issue 9, p164 

    Discusses an oral medication which may be used by patients with advanced colorectal cancer instead of undergoing intravenous chemotherapy treatment. Side effects of the drug, capecitabine.

  • Continuing Education.  // American Journal of Health-System Pharmacy;May2006 Supplement, Vol. 63, pS22 

    A quiz concerning the evolution in the management of colorectal cancer is presented.

  • New oncology agent treats colorectal cancer. Rodgers, Katie // Drug Topics;7/22/96, Vol. 140 Issue 14, p34 

    Details the approval given by the United States Food and Drug Administration to the oncology agent Camptosar, generically known as irinotecan and classified as a topoisomerase 1 inhibitor, used in the treatment of metastatic colorectal cancer. Manufacturer of the drug; Efficacy and safety;...

  • Cediranib failed to improve FOLFOX/CAPOX survival outcomes.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p24 

    The article reports on the results of the HORIZON II study, which shows that the addition of cediranib to chemotherapy did not enhance survival in patients with previously untreated metastatic colorectal cancer.

  • Cetuximab.  // Reactions Weekly;12/17/2011, Issue 1382, p15 

    The article describes the case of a 46-year-old patient with metastatic colon cancer who developed a pruritic exanthema and pustular folliculitis during chemotherapy with cetuximab.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics